RUNX2 rs145364349: Skeletal Genetics and Standing Height
The genetic variant rs145364349 is a single nucleotide polymorphism situated within the regulatory vicinity of the RUNX2 gene on chromosome 6. Research has identified limited statistical associations between this variant, skeletal development, and variations in standing height relevant to biomechanical leverage. Because RUNX2 is a master regulator of bone formation, subtle regulatory variations may mildly influence skeletal dimensions without causing clinical bone pathology.
What each genotype means
Typical skeletal growth baseline
You carry two copies of the common C reference allele in the RUNX2 regulatory region. Published association research links this background with typical baseline rates of skeletal morphogenesis and standard polygenic contributions to standing height. Because height is influenced by thousands of genetic loci and environment, this genotype alone has minimal overall influence.
Carried by approximately 94% to 98% of individuals across European and admixed populations in gnomAD.
Slightly altered skeletal leverage marker
You carry one copy of the uncommon T allele located near the RUNX2 locus. Preliminary genome-wide association studies suggest this variant may show a modest association with variations in skeletal growth dynamics and standing height relevant to biomechanical proportions. However, evidence remains limited and this variant does not cause or diagnose any skeletal disorders.
Carried by roughly 2% to 6% of individuals in European and admixed American populations; rarer in East Asian groups.
Uncommon skeletal growth marker
You carry two copies of the uncommon T allele in the regulatory region of the RUNX2 gene. Research into this variant's association with adult height and skeletal dimensions is limited, though carrying two copies reflects the less frequent end of normal polygenic height variation. It reflects subtle population-level statistical differences rather than a medical diagnosis or skeletal impairment.
Very rare, observed in fewer than 1 in 1,000 individuals globally.
Genomic Location and Variant Profile
The single nucleotide polymorphism cataloged as rs145364349 is located in the non-coding regulatory architecture of the RUNX2 gene on the short arm of human chromosome 6 (6p21.1). In the human genome assembly, this locus consists of a common ancestral allele alongside a low-frequency alternative allele. Because it lies within a putative gene regulatory region rather than within a protein-coding exon, the variant does not alter the underlying amino acid sequence of the resulting protein. Instead, variants in regulatory regions typically exert their effects by altering transcription factor binding sites, enhancer activity, or local chromatin architecture. This can subtly modulate the timing, tissue distribution, or total quantity of RUNX2 mRNA produced during key developmental windows, such as embryonic osteogenesis and longitudinal growth during puberty.
The Biological Role of the RUNX2 Master Regulator
The RUNX2 gene encodes Runt-related transcription factor 2, which serves as a master transcriptional regulator essential for osteoblast differentiation and skeletal morphogenesis. RUNX2 directs the commitment of multipotent mesenchymal stem cells into the osteoblastic lineage and drives the expression of vital downstream bone matrix proteins, such as osteocalcin and type I collagen. It also coordinates chondrocyte maturation during endochondral ossification, the foundational process that enables long bones to lengthen. Severe loss-of-function coding mutations or deletions in RUNX2 cause cleidocranial dysplasia, a rare genetic disorder characterized by hypoplastic clavicles, delayed cranial suture closure, and distinct dental abnormalities. In contrast, common and low-frequency regulatory variants like rs145364349 do not disable the gene but rather introduce subtle fluctuations in expression that contribute to normal, polygenic human phenotypic diversity.
Association with Standing Height and Biomechanical Leverage
Genome-wide association studies (GWAS) and skeletal genetics research have linked the genomic region surrounding RUNX2 to standing height and anthropometric leverage traits. Biomechanical leverage refers to how skeletal segment lengths—such as the ratio of femur to tibia or overall limb length—affect mechanical force generation and movement efficiency. Current evidence linking rs145364349 specifically to anthropometric metrics remains limited and modest in effect size. Height and skeletal proportions are classic polygenic traits governed by thousands of variants, each contributing fractions of a millimeter to total height. Carrier status for a single regulatory variant in RUNX2 does not dictate a distinct phenotype or determine an individual's athletic capability. Furthermore, statistical associations observed in population-wide cohorts reflect population averages rather than deterministic outcomes for any individual.
Population Distribution and Allele Frequencies
Data from large-scale reference databases, including the Genome Aggregation Database (gnomAD), indicate that rs145364349 is an uncommon or low-frequency variant across global populations. The minor allele displays an estimated frequency of approximately 0.01 to 0.03 (1% to 3%) across European and admixed American population groups, while it is observed at even lower frequencies or remains uncharacterized in certain other continental ancestries. Because of this distribution, the vast majority of individuals carry two copies of the major reference allele, with only a small minority inheriting one copy of the minor variant allele. Homozygous carriers of the minor allele are exceptionally rare in population cohorts. These baseline frequencies are essential for researchers studying whether specific regulatory variants show evidence of evolutionary selection across different geographic ancestral backgrounds.
Clinical Utility and Lifestyle Considerations
Learning one's genotype at rs145364349 does not offer diagnostic utility or warrant specific medical action. The variant is not a clinical marker for metabolic bone disease, osteopenia, or skeletal dysplasia, nor does it possess established pharmacogenomic guidelines. An individual's standing height, bone mineral density, and physical leverage are shaped primarily by the interplay of hundreds of genetic loci alongside critical non-genetic factors. These environmental influences include childhood nutrition, endocrine health, physical load-bearing exercise, and overall health status. Individuals curious about their skeletal health should rely on standard medical wellness metrics, adequate dietary calcium and vitamin D intake, and resistance training rather than attempting to tailor training or lifestyle choices based on an isolated non-coding variant.
How common is this variant?
The minor allele frequency for rs145364349 ranges between approximately 0.01 and 0.03 in European and admixed American populations according to gnomAD, with the reference homozygous genotype representing the vast majority of individuals globally.
Frequently asked questions
Can rs145364349 determine my final adult height?
No. Human height is a highly polygenic trait influenced by thousands of genetic variants alongside childhood nutrition, sleep, and endocrine factors. The rs145364349 variant accounts for only an infinitesimal fraction of height variation and cannot reliably predict standing stature.
Does having the minor allele mean I have cleidocranial dysplasia?
No. Cleidocranial dysplasia is caused by severe loss-of-function coding mutations or deletions in the RUNX2 gene that disrupt essential protein structure. Regulatory single nucleotide polymorphisms like rs145364349 are benign, low-frequency variations that do not cause monogenic skeletal disorders.
Does this genetic variant affect athletic performance or biomechanics?
While researchers study RUNX2 loci to understand skeletal dimensions and theoretical biomechanical leverage, isolated variants do not dictate sports performance. Athletic capability is determined by a complex combination of cardiovascular fitness, neuromuscular coordination, focused training, and polygenic traits.
Is any medical testing or intervention required for this genotype?
No clinical guidelines, diagnostic follow-ups, or medical treatments exist for rs145364349 genotypes. Standard recommendations for skeletal health—such as sufficient dietary calcium and vitamin D intake alongside regular weight-bearing exercise—apply universally regardless of your genotype.
Sources & further reading
Educational information only, last refreshed 9/14/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs145364349?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29